A recent study published in JAMA Neurology explores the effect of elevated amyloid levels on subsequent changes in cognition and biomarkers. The findings indicate that in normal people, elevated levels of amyloid can signal cognitive decline. While the authors are not suggesting that these findings should impact current clinical recommendations, the conclusions could impact clinical trials for testing amyloid levels.
Last month, RadSite journeyed to Chicago for the Radiological Society of North America’s (RSNA) 101st Scientific Assembly and Annual Meeting. The largest radiology-focused event in the world, 51,922 attendees flocked to RSNA 2015 from all over the globe. RadSite was one of 661 exhibitors participating in the conference, and we enjoyed the opportunity to connect with attendees to highlight the differentiating factors of our MIPPA Accreditation Program (MAP) and learn more about their needs and wants when it comes to the topic. Our conversations made it apparent that the RadSite experience is distinct.
Legalities in health care can often make this important practice muddled at best—especially in the field of radiology and for facilities using PACS. In the first part of a two part series, Eliot Siegel, MD, discusses who really owns medical images, how to deal with bankruptcy in an imaging facility and why physicians don’t use image compression more often.
Proper equipment calibration and maintenance are some of the most critical components of making sure your imaging systems are safe and produce quality images. Medical physicists are extremely important players in this arena, bridging the gap between technologists and physicians to make sure diagnostic imaging equipment is functioning optimally. In this one-hour session, Phillip Patton, PhD, CHP, DABR, DABSNM, reviews basic components of physics testing for ADI systems, highlights key differences in state requirements for physicists and explains why it is important to hire a qualified medical physicist for your physics testing when applying for RadSite Accreditation.
The Protecting Access to Medicare Act (PAMA) was signed into law on April 1, 2014, mandating all physicians and ordering professionals in the Medicare program to consult with a qualified Clinical Decision Support (CDS) software based on appropriate use criteria (AUC) for ordering advanced imaging studies such as diagnostic MRI, CT and nuclear medicine or PET services. Continue reading to find out all the details and reactions throughout the medical imaging industry.